Preimplantation Genetic Testing Market (2022 - 2032)
Preimplantation Genetic Testing Market Analysis, By Test Type (Diagnostics, Screening), By Application (Embryo HLA Typing, IVF Prognosis, Late-Onset Genetic Disorders), By Technology (NGS-based, PCR-based, FISH-based), By Sales Type, By End Use, By Region - Global Market Insights 2022 to 2032
Core Findings
FREE CustomizationPreimplantation Genetic Testing Market Outlook (2022 to 2032)
The preimplantation genetic testing market is projected to grow at nearly 9% CAGR and is likely to register an impressive valuation through 2032. The increasing prevalence of genetic disorders is broadening growth prospects.
As of 2022, the market is likely to reach US$ 653.52 Million, and will further accelerate to reach US$ 1,420 Million by 2032.
| Report Attributes | Details |
|---|---|
| Preimplantation Genetic Testing Market Size (2022) | US$ 653.52 Million |
| Projected Market Value (2032F) | US$ 1,420 Million |
| Global Market Growth Rate (2022 to 2032) | 9% CAGR |
| Asia Pacific Market Share (2022) | 60% |
| North America Market Share (2022) | 25% |
| Key Companies Profiled | Agilent Technologies Inc.; Abbott Laboratories; CooperSurgical Inc.; Oxford Gene Technology IP; Illumina Inc.; Thermo Fisher Scientific Inc.; PerkinElmer Inc.; Genea Limited; Natera Inc.; Rubicon Genomics Inc.; CombiMatrix Corporation |
The Asia Pacific contributes a major share of the global market due to rapid advancements in the healthcare industry developments in countries such as India, China, Indonesia, and Vietnam.
The increasing acceptance of embryo HLA typing for stem cell therapy and improving healthcare infrastructure sector in the region is also expected to boost demand for Preimplantation Genetic Testing to US$ 1,420 Mn by 2032.
Preimplantation Genetic Testing Demand Analysis (2017 to 2021) in Comparison to Market Estimations (2022 to 2032)
As per Fact.MR - market research and competitive intelligence provider- over the last 5 years, the global market for preimplantation genetic testing expanded at an 8% CAGR. In 2020, the market was valued at around US$ 550 Million.
Preimplantation genetic testing is gaining traction for diagnosing minor disabilities and other serious diseases such as cancer. Researchers are also focusing on using innovative techniques for eliminating the possibility of embryo destruction while preimplantation genetic testing.
All these factors create an ideal environment for preimplantation genetic testing across the world, and the market is expected to show an impressive valuation by 2032, expanding at nearly 9% CAGR.
What’s driving the Growth of the Global Preimplantation Genetic Testing Market?
Increasing Prevalence of Genetic Screening across Specialized Clinics to Fuel Global Demand
Genetic screening is expected to be the most preferred preimplantation genetic testing approach. The section is projected to gain a nearly 2/3rd share of the market for preimplantation genetic testing in terms of revenue until 2032.
According to the Centers for Disease Control and Prevention (CDC), chronic ailments such as cancer, heart disorders, and diabetes are the leading cause of disability and death in people across the United States.
The country’s healthcare system spends nearly US$ 3 Billion annually on direct and indirect costs. In addition to this, the increasing awareness regarding the effectiveness of genetic testing methods amongst healthcare professionals is projected to favor market growth in forthcoming years.
Amongst all end users, specialized clinics are expected to experience strong growth. They are estimated to exceed the US$ 200 Million revenue threshold during the forecast period. Meanwhile, hospitals are also expected to witness impressive growth in the global market for preimplantation genetic testing through 2032.
In June 2020, The U.S. Food and Drug Administration issued an emergency use authorization (EUA) to Illumina, Inc. for the first COVID-19 diagnostic test utilizing next-generation sequence technology. The FDA authorized the Illumina COVIDSeq Test for the qualitative detection of SARS-CoV-2 RNA from respiratory specimens collected from individuals suspected of COVID-19 by their healthcare provider.
What are the Key Challenges Faced by Manufacturers of Preimplantation Genetic Testing?
Higher Cost of Testing May Impede the Market Growth
Despite several benefits, this genetic testing comes with a few restraints that impact market growth. High costs associated with preimplantation genetic testing and unfavorable government regulations are the perennial challenges to market growth. In Addition, a dearth of awareness in poor countries may restrain the growth of preimplantation genetic testing.
How Crucial is Development in the Preimplantation Genetic Testing Market for Start-ups?
Rapid Advancement by New Entrants to Elevate Demand for Preimplantation Genetic Testing
Witnessing the immense growth in the genome treatment sector, emerging startups are making efforts to provide effective testing services to clinicians for pre-implantation genetic diagnosis (PGD), mutation screening, and prenatal testing. These efforts are likely to amplify the global acceptance of genetic testing for its application in several fields.
For instance, In June 2022, Natera, Inc., a global leader in cell-free DNA testing, announced at the Canaccord Genuity 42nd Annual Growth Conference in Boston that the company has proactively filed a pre-submission to the FDA for its Panorama® non-invasive prenatal test (NIPT) as part of the Q-Sub process. The company filed its pre-submission for fetal chromosomal aneuploidies and 22q11.2 deletion syndrome.
Along with this, another key start-up, Progenity is offering an option of non-invasive testing. The company's diagnostic platform is based on genomics, epigenomics, proteomics, and metabolomics.
Which Regional Market is catching the Attention of Preimplantation Genetic Testing Suppliers?
North America Offers the Largest Opportunity for Preimplantation Genetic Testing Providers
In 2021, North America surpassed Europe as the leading region in the Preimplantation Genetics Diagnosis (PGD) market, accounting for the highest sales. This growth is attributed to an increase in the country's population and money spent on healthcare.
As of 2021, 489 fertility clinics in the United States offer ART solutions, as per the report published by the US Department of Health and Human Services. The states with the maximum proportion of ART births are Massachusetts, Columbia, and New Jersey. In addition, a growing number of chromosome abnormality cases in the region leads to various genetic disorders. A CAGR of 7% has been projected for the market.
According to CDC, each year, about 6,000 babies are born with Down syndrome, which is about 1 in every 700 babies born. Down syndrome among newborn babies in the U.S continues to be the most common chromosomal disorder, broadening the scope of preimplantation genetic testing across the North American region.
Country-wise Analysis
What is the Demand Outlook for Preimplantation Genetic Testing in the U.K?
Increasing Prevalence of Genetic Disorders to Bolster Demand for these Testing
The UK is projected to be the most lucrative market for preimplantation genetic testing across Europe. Fact.MR estimates a CAGR of around 8% for the U.K market across the forecast period. In 2021, the market demand is projected to bolster, owing to the presence of various healthcare institutions and hospitals providing preimplantation genetic testing and high awareness due to the various initiatives by the government.
Moreover, genetic testing in the U.K. is increasing as the country amid a high incidence of genetic disorders. According to Genetic Alliance, it is estimated that at least 1 child out of 25 is affected by a genetic disorder. This means that 30,000 babies are diagnosed each year and more than 500 million children and adults are living with a genetic disorder. Owing to these factors, the market is projected to expand through 2032.
What are the Growth Opportunities for Preimplantation Genetic Testing across India and China?
China Presents Robust Opportunities
Emerging economies such as China and India are experiencing numerous advancements in their respective healthcare sectors. Reproductive health is especially accompanied by the launch of several supportive governmental legislations. Collectively, both regions are expected to contribute nearly 60% of total revenue.
The presence of regulatory bodies, such as the Indian Ministry of Health & Family Welfare, which approve and monitor the challenges associated with reproductive health in India: is anticipated to bode well for regional growth of the market for preimplantation genetic testing.
Category-Wise Analysis
How is Demand for Embryo HLA typing for Stem Cell Therapy Gaining Ground?
Embryo HLA typing Applications to Garner two-fifth Market Share
Preimplantation genetic testing is likely to find maximum application in embryo HLA typing for stem cell therapy. Accounting for more than 40% of revenue, embryo HLA typing for stem cell therapy is projected to generate an incremental opportunity exceeding US$ 70 Million by 2032.
How is Next-Generation Sequencing Technology Generating Demand?
Soaring Investments in NGS to Accelerate Market Growth
Next-generation sequencing (NGS) is expected to be the dominant preimplantation genetic testing technology. NGS is estimated to exceed US$ 200 Million in revenue during the forecast period.
According to the Centers for Disease Control and Prevention during the past 5 years, NGS has transitioned from research to clinical use. At least 14 countries have created initiatives to sequence large populations, and it is projected that more than 60 million people worldwide will have their genomes sequenced by 2025.
Competitive Landscape
- In May 2021, United Airlines and Abbott Laboratories announced a collaboration to use Abbott’s BinaxNOW™ COVID-19 Home Test and Abbott’s NAVICA app to help make the international travel experience more seamless.
- In March 2021, Agilent Technologies Inc., entered into a definitive agreement to acquire Resolution Bioscience Inc., a leader in the development and commercialization of next-generation sequencing (NGS)-based precision oncology solutions.
- In June 2021, Thermo Fisher Scientific and First Genetics JCS, a manufacturer of diagnostic equipment and IVD kits intended to advance molecular genetic technologies into clinical practice, today announced a strategic partnership focused on commercializing next-generation sequencing (NGS)-based diagnostics in Russia. The agreement enables First Genetics to market its F-Genetics NGS System and IVD assays to Russian labs for reproductive health testing and cancer diagnostics. The F-Genetics System is based on Thermo Fisher's Ion GeneStudio S5 System.
Key Segments in Preimplantation Genetic Testing Industry Research
-
By Test Type :
- Diagnostics
- Screening
-
By End User :
- Hospitals
- Diagnostic Labs
- Research & Academic Institutions
- Specialized Clinics
- Others
-
By Application :
- Embryo HLA Typing for Stem Cell Therapy
- IVF Prognosis
- Late-Onset Genetic Disorders
- Inherited Genetic Diseases
- Other
-
By Technology :
- NGS-based
- PCR-based
- FISH-based
- CGH-based
- SNP-based
-
By Region :
- North America
- Latin America
- Europe
- Japan
- APEJ
- Middle East Africa
Table of Content
- 1. Global Market - Executive Summary
- 2. Global Market Overview
- 3. Global Market Analysis and Forecast by Test Type
- 3.1. Genetic Diagnosis
- 3.2. Genetic Screening
- 4. Global Market Analysis and Forecast by End User
- 4.1. Hospitals
- 4.2. Diagnostic Labs
- 4.3. Research & Academic Institutes
- 4.4. Specialized Clinics
- 4.5. Other End Users
- 5. Global Market Analysis and Forecast by Application
- 5.1. Embryo HLA Typing for Stem Cell Therapy
- 5.2. IVF Prognosis
- 5.3. Late-Onset Genetic Disorders
- 5.4. Inherited Genetic Disease
- 5.5. Other Applications
- 6. Global Market Analysis and Forecast by Technology
- 6.1. NGS
- 6.2. PCR
- 6.3. FISH
- 6.4. CGH
- 6.5. SNP
- 7. Global Market Analysis and Forecast By Region
- 7.1. North America
- 7.2. Latin America
- 7.3. Europe
- 7.4. Japan
- 7.5. APEJ
- 7.6. MEA
- 8. North America Market Analysis and Forecast, By Country, 2017 to 2032
- 9. Latin America Market Analysis and Forecast, By Country, 2017 to 2032
- 10. Europe Market Analysis and Forecast, By Country, 2017 to 2032
- 11. Japan Market Analysis and Forecast, 2017 to 2032
- 12. APEJ Market Analysis and Forecast, By Country, 2017 to 2032
- 13. MEA Market Analysis and Forecast, By Country, 2017 to 2032
- 14. Global Market Company Share, Competition Landscape and Company Profiles
- 14.1. Abbott Laboratories
- 14.2. Agilent Technologies, Inc.
- 14.3. Coopersurgical, Inc.
- 14.4. Illumina, Inc.
- 14.5. Oxford Gene Technology
- 14.6. Perkinelmer, Inc.
- 14.7. Thermo Fisher Scientific, Inc.
- 14.8. Natera, Inc.
- 14.9. CombiMatrix Corporation
- 14.10. Rubicon Genomics, Inc.
- 14.11. Genea Limited
- 15. Research Methodology
- 16. Secondary and Primary Sources
- 17. Assumptions and Acronyms
- 18. Disclaimer
List Of Table
TABLE 01: Global Market Value (US$ Mn), 2017 to 2021
TABLE 02: Global Market Value (US$ Mn), 2022 to 2032
TABLE 03: Global Market Value (US$ Mn) and Y-o-Y, 2017 to 2032
TABLE 04: Global Genetic Diagnosis Segment Value (US$ Mn), By Region 2017 to 2021
TABLE 05: Global Genetic Diagnosis Segment Value (US$ Mn), By Region 2022 to 2032
TABLE 06: Global Genetic Diagnosis Segment Market Share, By Region 2017 to 2021
TABLE 07: Global Genetic Diagnosis Segment Market Share, By Region 2022 to 2032
TABLE 08: Global Genetic Diagnosis Segment Y-o-Y, By Region 2017 to 2032
TABLE 09: Global Genetic Screening Segment Value (US$ Mn), By Region 2017 to 2021
TABLE 10: Global Genetic Screening Segment Value (US$ Mn), By Region 2022 to 2032
TABLE 11: Global Genetic Screening Segment Market Share, By Region 2017 to 2021
TABLE 12: Global Genetic Screening Segment Market Share, By Region 2022 to 2032
TABLE 13: Global Genetic Screening Segment Y-o-Y, By Region 2017 to 2032
TABLE 14: Global Hospitals Segment Value (US$ Mn), By Region 2017 to 2021
TABLE 15: Global Hospitals Segment Value (US$ Mn), By Region 2022 to 2032
TABLE 16: Global Hospitals Segment Market Share, By Region 2017 to 2021
TABLE 17: Global Hospitals Segment Market Share, By Region 2022 to 2032
TABLE 18: Global Hospitals Segment Y-o-Y, By Region 2017 to 2032
TABLE 19: Global Diagnostic Labs Segment Value (US$ Mn), By Region 2017 to 2021
TABLE 20: Global Diagnostic Labs Segment Value (US$ Mn), By Region 2022 to 2032
TABLE 21: Global Diagnostic Labs Segment Market Share, By Region 2017 to 2021
TABLE 22: Global Diagnostic Labs Segment Market Share, By Region 2022 to 2032
TABLE 23: Global Diagnostic Labs Segment Y-o-Y, By Region 2017 to 2032
TABLE 24: Global Research & Academic Institutes Segment Value (US$ Mn), By Region 2017 to 2021
TABLE 25: Global Research & Academic Institutes Segment Value (US$ Mn), By Region 2022 to 2032
TABLE 26: Global Research & Academic Institutes Segment Market Share, By Region 2017 to 2021
TABLE 27: Global Research & Academic Institutes Segment Market Share, By Region 2022 to 2032
TABLE 28: Global Research & Academic Institutes Segment Y-o-Y, By Region 2017 to 2032
TABLE 29: Global Specialized Clinics Segment Value (US$ Mn), By Region 2017 to 2021
TABLE 30: Global Specialized Clinics Segment Value (US$ Mn), By Region 2022 to 2032
TABLE 31: Global Specialized Clinics Segment Market Share, By Region 2017 to 2021
TABLE 32: Global Specialized Clinics Segment Market Share, By Region 2022 to 2032
TABLE 33: Global Specialized Clinics Segment Y-o-Y, By Region 2017 to 2032
TABLE 34: Global Other End Users Segment Value (US$ Mn), By Region 2017 to 2021
TABLE 35: Global Other End Users Segment Value (US$ Mn), By Region 2022 to 2032
TABLE 36: Global Other End Users Segment Market Share, By Region 2017 to 2021
TABLE 37: Global Other End Users Segment Market Share, By Region 2022 to 2032
TABLE 38: Global Other End Users Segment Y-o-Y, By Region 2017 to 2032
TABLE 39: Global Embryo HLA Typing for Stem Cell Therapy Segment Value (US$ Mn), By Region 2017 to 2021
TABLE 40: Global Embryo HLA Typing for Stem Cell Therapy Segment Value (US$ Mn), By Region 2022 to 2032
TABLE 41: Global Embryo HLA Typing for Stem Cell Therapy Segment Market Share, By Region 2017 to 2021
TABLE 42: Global Embryo HLA Typing for Stem Cell Therapy Segment Market Share, By Region 2022 to 2032
TABLE 43: Global Embryo HLA Typing for Stem Cell Therapy Segment Y-o-Y, By Region 2017 to 2032
TABLE 44: Global IVF Prognosis Segment Value (US$ Mn), By Region 2017 to 2021
TABLE 45: Global IVF Prognosis Segment Value (US$ Mn), By Region 2022 to 2032
TABLE 46: Global IVF Prognosis Segment Market Share, By Region 2017 to 2021
TABLE 47: Global IVF Prognosis Segment Market Share, By Region 2022 to 2032
TABLE 48: Global IVF Prognosis Segment Y-o-Y, By Region 2017 to 2032
TABLE 49: Global Late-Onset Genetic Disorders Segment Value (US$ Mn), By Region 2017 to 2021
TABLE 50: Global Late-Onset Genetic Disorders Segment Value (US$ Mn), By Region 2022 to 2032
TABLE 51: Global Late-Onset Genetic Disorders Segment Market Share, By Region 2017 to 2021
TABLE 52: Global Late-Onset Genetic Disorders Segment Market Share, By Region 2022 to 2032
TABLE 53: Global Late-Onset Genetic Disorders Segment Y-o-Y, By Region 2017 to 2032
TABLE 54: Global Inherited Genetic Disease Segment Value (US$ Mn), By Region 2017 to 2021
TABLE 55: Global Inherited Genetic Disease Segment Value (US$ Mn), By Region 2022 to 2032
TABLE 56: Global Inherited Genetic Disease Segment Market Share, By Region 2017 to 2021
TABLE 57: Global Inherited Genetic Disease Segment Market Share, By Region 2022 to 2032
TABLE 58: Global Inherited Genetic Disease Segment Y-o-Y, By Region 2017 to 2032
TABLE 59: Global Other Applications Segment Value (US$ Mn), By Region 2017 to 2021
TABLE 60: Global Other Applications Segment Value (US$ Mn), By Region 2022 to 2032
TABLE 61: Global Other Applications Segment Market Share, By Region 2017 to 2021
TABLE 62: Global Other Applications Segment Market Share, By Region 2022 to 2032
TABLE 63: Global Other Applications Segment Y-o-Y, By Region 2017 to 2032
TABLE 64: Global NGS Segment Value (US$ Mn), By Region 2017 to 2021
TABLE 65: Global NGS Segment Value (US$ Mn), By Region 2022 to 2032
TABLE 66: Global NGS Segment Market Share, By Region 2017 to 2021
TABLE 67: Global NGS Segment Market Share, By Region 2022 to 2032
TABLE 68: Global NGS Segment Y-o-Y, By Region 2017 to 2032
TABLE 69: Global PCR Segment Value (US$ Mn), By Region 2017 to 2021
TABLE 70: Global PCR Segment Value (US$ Mn), By Region 2022 to 2032
TABLE 71: Global PCR Segment Market Share, By Region 2017 to 2021
TABLE 72: Global PCR Segment Market Share, By Region 2022 to 2032
TABLE 73: Global PCR Segment Y-o-Y, By Region 2017 to 2032
TABLE 74: Global FISH Segment Value (US$ Mn), By Region 2017 to 2021
TABLE 75: Global FISH Segment Value (US$ Mn), By Region 2022 to 2032
TABLE 76: Global FISH Segment Market Share, By Region 2017 to 2021
TABLE 77: Global FISH Segment Market Share, By Region 2022 to 2032
TABLE 78: Global FISH Segment Y-o-Y, By Region 2017 to 2032
TABLE 79: Global CGH Segment Value (US$ Mn), By Region 2017 to 2021
TABLE 80: Global CGH Segment Value (US$ Mn), By Region 2022 to 2032
TABLE 81: Global CGH Segment Market Share, By Region 2017 to 2021
TABLE 82: Global CGH Segment Market Share, By Region 2022 to 2032
TABLE 83: Global CGH Segment Y-o-Y, By Region 2017 to 2032
TABLE 84: Global SNP Segment Value (US$ Mn), By Region 2017 to 2021
TABLE 85: Global SNP Segment Value (US$ Mn), By Region 2022 to 2032
TABLE 86: Global SNP Segment Market Share, By Region 2017 to 2021
TABLE 87: Global SNP Segment Market Share, By Region 2022 to 2032
TABLE 88: Global SNP Segment Y-o-Y, By Region 2017 to 2032
TABLE 89: North America Market Value (US$ Mn), By Test Type 2017 to 2021
TABLE 90: North America Market Value (US$ Mn), By Test Type 2022 to 2032
TABLE 91: North America Market Value (US$ Mn), By End User 2017 to 2021
TABLE 92: North America Market Value (US$ Mn), By End User 2022 to 2032
TABLE 93: North America Market Value (US$ Mn), By Application 2017 to 2021
TABLE 94: North America Market Value (US$ Mn), By Application 2022 to 2032
TABLE 95: North America Market Value (US$ Mn), By Technology 2017 to 2021
TABLE 96: North America Market Value (US$ Mn), By Technology 2022 to 2032
TABLE 97: Latin America Market Value (US$ Mn), By Test Type 2017 to 2021
TABLE 98: Latin America Market Value (US$ Mn), By Test Type 2022 to 2032
TABLE 99: Latin America Market Value (US$ Mn), By End User 2017 to 2021
TABLE 100: Latin America Market Value (US$ Mn), By End User 2022 to 2032
TABLE 101: Latin America Market Value (US$ Mn), By Application 2017 to 2021
TABLE 102: Latin America Market Value (US$ Mn), By Application 2022 to 2032
TABLE 103: Latin America Market Value (US$ Mn), By Technology 2017 to 2021
TABLE 104: Latin America Market Value (US$ Mn), By Technology 2022 to 2032
TABLE 105: Europe Market Value (US$ Mn), By Test Type 2017 to 2021
TABLE 106: Europe Market Value (US$ Mn), By Test Type 2022 to 2032
TABLE 107: Europe Market Value (US$ Mn), By End User 2017 to 2021
TABLE 108: Europe Market Value (US$ Mn), By End User 2022 to 2032
TABLE 109: Europe Market Value (US$ Mn), By Application 2017 to 2021
TABLE 110: Europe Market Value (US$ Mn), By Application 2022 to 2032
TABLE 111: Europe Market Value (US$ Mn), By Technology 2017 to 2021
TABLE 112: Europe Market Value (US$ Mn), By Technology 2022 to 2032
TABLE 113: Japan Market Value (US$ Mn), By Test Type 2017 to 2021
TABLE 114: Japan Market Value (US$ Mn), By Test Type 2022 to 2032
TABLE 115: Japan Market Value (US$ Mn), By End User 2017 to 2021
TABLE 116: Japan Market Value (US$ Mn), By End User 2022 to 2032
TABLE 117: Japan Market Value (US$ Mn), By Application 2017 to 2021
TABLE 118: Japan Market Value (US$ Mn), By Application 2022 to 2032
TABLE 119: Japan Market Value (US$ Mn), By Technology 2017 to 2021
TABLE 120: Japan Market Value (US$ Mn), By Technology 2022 to 2032
TABLE 121: APEJ Market Value (US$ Mn), By Test Type 2017 to 2021
TABLE 122: APEJ Market Value (US$ Mn), By Test Type 2022 to 2032
TABLE 123: APEJ Market Value (US$ Mn), By End User 2017 to 2021
TABLE 124: APEJ Market Value (US$ Mn), By End User 2022 to 2032
TABLE 125: APEJ Market Value (US$ Mn), By Application 2017 to 2021
TABLE 126: APEJ Market Value (US$ Mn), By Application 2022 to 2032
TABLE 127: APEJ Market Value (US$ Mn), By Technology 2017 to 2021
TABLE 128: APEJ Market Value (US$ Mn), By Technology 2022 to 2032
TABLE 129: MEA Market Value (US$ Mn), By Test Type 2017 to 2021
TABLE 130: MEA Market Value (US$ Mn), By Test Type 2022 to 2032
TABLE 131: MEA Market Value (US$ Mn), By End User 2017 to 2021
TABLE 132: MEA Market Value (US$ Mn), By End User 2022 to 2032
TABLE 133: MEA Market Value (US$ Mn), By Application 2017 to 2021
TABLE 134: MEA Market Value (US$ Mn), By Application 2022 to 2032
TABLE 135: MEA Market Value (US$ Mn), By Technology 2017 to 2021
TABLE 136: MEA Market Value (US$ Mn), By Technology 2022 to 2032
TABLE 137: US Market Value (US$ Mn), By Test Type 2017 to 2021
TABLE 138: US Market Value (US$ Mn), By Test Type 2022 to 2032
TABLE 139: US Market Value (US$ Mn), By End User 2017 to 2021
TABLE 140: US Market Value (US$ Mn), By End User 2022 to 2032
TABLE 141: US Market Value (US$ Mn), By Application 2017 to 2021
TABLE 142: US Market Value (US$ Mn), By Application 2022 to 2032
TABLE 143: US Market Value (US$ Mn), By Technology 2017 to 2021
TABLE 144: US Market Value (US$ Mn), By Technology 2022 to 2032
TABLE 145: Canada Market Value (US$ Mn), By Test Type 2017 to 2021
TABLE 146: Canada Market Value (US$ Mn), By Test Type 2022 to 2032
TABLE 147: Canada Market Value (US$ Mn), By End User 2017 to 2021
TABLE 148: Canada Market Value (US$ Mn), By End User 2022 to 2032
TABLE 149: Canada Market Value (US$ Mn), By Application 2017 to 2021
TABLE 150: Canada Market Value (US$ Mn), By Application 2022 to 2032
TABLE 151: Canada Market Value (US$ Mn), By Technology 2017 to 2021
TABLE 152: Canada Market Value (US$ Mn), By Technology 2022 to 2032
TABLE 153: Argentina Market Value (US$ Mn), By Test Type 2017 to 2021
TABLE 154: Argentina Market Value (US$ Mn), By Test Type 2022 to 2032
TABLE 155: Argentina Market Value (US$ Mn), By End User 2017 to 2021
TABLE 156: Argentina Market Value (US$ Mn), By End User 2022 to 2032
TABLE 157: Argentina Market Value (US$ Mn), By Application 2017 to 2021
TABLE 158: Argentina Market Value (US$ Mn), By Application 2022 to 2032
TABLE 159: Argentina Market Value (US$ Mn), By Technology 2017 to 2021
TABLE 160: Argentina Market Value (US$ Mn), By Technology 2022 to 2032
TABLE 161: Brazil Market Value (US$ Mn), By Test Type 2017 to 2021
TABLE 162: Brazil Market Value (US$ Mn), By Test Type 2022 to 2032
TABLE 163: Brazil Market Value (US$ Mn), By End User 2017 to 2021
TABLE 164: Brazil Market Value (US$ Mn), By End User 2022 to 2032
TABLE 165: Brazil Market Value (US$ Mn), By Application 2017 to 2021
TABLE 166: Brazil Market Value (US$ Mn), By Application 2022 to 2032
TABLE 167: Brazil Market Value (US$ Mn), By Technology 2017 to 2021
TABLE 168: Brazil Market Value (US$ Mn), By Technology 2022 to 2032
TABLE 169: Mexico Market Value (US$ Mn), By Test Type 2017 to 2021
TABLE 170: Mexico Market Value (US$ Mn), By Test Type 2022 to 2032
TABLE 171: Mexico Market Value (US$ Mn), By End User 2017 to 2021
TABLE 172: Mexico Market Value (US$ Mn), By End User 2022 to 2032
TABLE 173: Mexico Market Value (US$ Mn), By Application 2017 to 2021
TABLE 174: Mexico Market Value (US$ Mn), By Application 2022 to 2032
TABLE 175: Mexico Market Value (US$ Mn), By Technology 2017 to 2021
TABLE 176: Mexico Market Value (US$ Mn), By Technology 2022 to 2032
TABLE 177: UK Market Value (US$ Mn), By Test Type 2017 to 2021
TABLE 178: UK Market Value (US$ Mn), By Test Type 2022 to 2032
TABLE 179: UK Market Value (US$ Mn), By End User 2017 to 2021
TABLE 180: UK Market Value (US$ Mn), By End User 2022 to 2032
TABLE 181: UK Market Value (US$ Mn), By Application 2017 to 2021
TABLE 182: UK Market Value (US$ Mn), By Application 2022 to 2032
TABLE 183: UK Market Value (US$ Mn), By Technology 2017 to 2021
TABLE 184: UK Market Value (US$ Mn), By Technology 2022 to 2032
TABLE 185: Germany Market Value (US$ Mn), By Test Type 2017 to 2021
TABLE 186: Germany Market Value (US$ Mn), By Test Type 2022 to 2032
TABLE 187: Germany Market Value (US$ Mn), By End User 2017 to 2021
TABLE 188: Germany Market Value (US$ Mn), By End User 2022 to 2032
TABLE 189: Germany Market Value (US$ Mn), By Application 2017 to 2021
TABLE 190: Germany Market Value (US$ Mn), By Application 2022 to 2032
TABLE 191: Germany Market Value (US$ Mn), By Technology 2017 to 2021
TABLE 192: Germany Market Value (US$ Mn), By Technology 2022 to 2032
TABLE 193: France Market Value (US$ Mn), By Test Type 2017 to 2021
TABLE 194: France Market Value (US$ Mn), By Test Type 2022 to 2032
TABLE 195: France Market Value (US$ Mn), By End User 2017 to 2021
TABLE 196: France Market Value (US$ Mn), By End User 2022 to 2032
TABLE 197: France Market Value (US$ Mn), By Application 2017 to 2021
TABLE 198: France Market Value (US$ Mn), By Application 2022 to 2032
TABLE 199: France Market Value (US$ Mn), By Technology 2017 to 2021
TABLE 200: France Market Value (US$ Mn), By Technology 2022 to 2032
TABLE 201: Spain Market Value (US$ Mn), By Test Type 2017 to 2021
TABLE 202: Spain Market Value (US$ Mn), By Test Type 2022 to 2032
TABLE 203: Spain Market Value (US$ Mn), By End User 2017 to 2021
TABLE 204: Spain Market Value (US$ Mn), By End User 2022 to 2032
TABLE 205: Spain Market Value (US$ Mn), By Application 2017 to 2021
TABLE 206: Spain Market Value (US$ Mn), By Application 2022 to 2032
TABLE 207: Spain Market Value (US$ Mn), By Technology 2017 to 2021
TABLE 208: Spain Market Value (US$ Mn), By Technology 2022 to 2032
TABLE 209: Italy Market Value (US$ Mn), By Test Type 2017 to 2021
TABLE 210: Italy Market Value (US$ Mn), By Test Type 2022 to 2032
TABLE 211: Italy Market Value (US$ Mn), By End User 2017 to 2021
TABLE 212: Italy Market Value (US$ Mn), By End User 2022 to 2032
TABLE 213: Italy Market Value (US$ Mn), By Application 2017 to 2021
TABLE 214: Italy Market Value (US$ Mn), By Application 2022 to 2032
TABLE 215: Italy Market Value (US$ Mn), By Technology 2017 to 2021
TABLE 216: Italy Market Value (US$ Mn), By Technology 2022 to 2032
TABLE 217: Nordic Market Value (US$ Mn), By Test Type 2017 to 2021
TABLE 218: Nordic Market Value (US$ Mn), By Test Type 2022 to 2032
TABLE 219: Nordic Market Value (US$ Mn), By End User 2017 to 2021
TABLE 220: Nordic Market Value (US$ Mn), By End User 2022 to 2032
TABLE 221: Nordic Market Value (US$ Mn), By Application 2017 to 2021
TABLE 222: Nordic Market Value (US$ Mn), By Application 2022 to 2032
TABLE 223: Nordic Market Value (US$ Mn), By Technology 2017 to 2021
TABLE 224: Nordic Market Value (US$ Mn), By Technology 2022 to 2032
TABLE 225: Japan Market Value (US$ Mn), By Test Type 2017 to 2021
TABLE 226: Japan Market Value (US$ Mn), By Test Type 2022 to 2032
TABLE 227: Japan Market Value (US$ Mn), By End User 2017 to 2021
TABLE 228: Japan Market Value (US$ Mn), By End User 2022 to 2032
TABLE 229: Japan Market Value (US$ Mn), By Application 2017 to 2021
TABLE 230: Japan Market Value (US$ Mn), By Application 2022 to 2032
TABLE 231: Japan Market Value (US$ Mn), By Technology 2017 to 2021
TABLE 232: Japan Market Value (US$ Mn), By Technology 2022 to 2032
TABLE 233: China Market Value (US$ Mn), By Test Type 2017 to 2021
TABLE 234: China Market Value (US$ Mn), By Test Type 2022 to 2032
TABLE 235: China Market Value (US$ Mn), By End User 2017 to 2021
TABLE 236: China Market Value (US$ Mn), By End User 2022 to 2032
TABLE 237: China Market Value (US$ Mn), By Application 2017 to 2021
TABLE 238: China Market Value (US$ Mn), By Application 2022 to 2032
TABLE 239: China Market Value (US$ Mn), By Technology 2017 to 2021
TABLE 240: China Market Value (US$ Mn), By Technology 2022 to 2032
TABLE 241: India Market Value (US$ Mn), By Test Type 2017 to 2021
TABLE 242: India Market Value (US$ Mn), By Test Type 2022 to 2032
TABLE 243: India Market Value (US$ Mn), By End User 2017 to 2021
TABLE 244: India Market Value (US$ Mn), By End User 2022 to 2032
TABLE 245: India Market Value (US$ Mn), By Application 2017 to 2021
TABLE 246: India Market Value (US$ Mn), By Application 2022 to 2032
TABLE 247: India Market Value (US$ Mn), By Technology 2017 to 2021
TABLE 248: India Market Value (US$ Mn), By Technology 2022 to 2032
TABLE 249: Malaysia Market Value (US$ Mn), By Test Type 2017 to 2021
TABLE 250: Malaysia Market Value (US$ Mn), By Test Type 2022 to 2032
TABLE 251: Malaysia Market Value (US$ Mn), By End User 2017 to 2021
TABLE 252: Malaysia Market Value (US$ Mn), By End User 2022 to 2032
TABLE 253: Malaysia Market Value (US$ Mn), By Application 2017 to 2021
TABLE 254: Malaysia Market Value (US$ Mn), By Application 2022 to 2032
TABLE 255: Malaysia Market Value (US$ Mn), By Technology 2017 to 2021
TABLE 256: Malaysia Market Value (US$ Mn), By Technology 2022 to 2032
TABLE 257: Australia Market Value (US$ Mn), By Test Type 2017 to 2021
TABLE 258: Australia Market Value (US$ Mn), By Test Type 2022 to 2032
TABLE 259: Australia Market Value (US$ Mn), By End User 2017 to 2021
TABLE 260: Australia Market Value (US$ Mn), By End User 2022 to 2032
TABLE 261: Australia Market Value (US$ Mn), By Application 2017 to 2021
TABLE 262: Australia Market Value (US$ Mn), By Application 2022 to 2032
TABLE 263: Australia Market Value (US$ Mn), By Technology 2017 to 2021
TABLE 264: Australia Market Value (US$ Mn), By Technology 2022 to 2032
TABLE 265: Singapore Market Value (US$ Mn), By Test Type 2017 to 2021
TABLE 266: Singapore Market Value (US$ Mn), By Test Type 2022 to 2032
TABLE 267: Singapore Market Value (US$ Mn), By End User 2017 to 2021
TABLE 268: Singapore Market Value (US$ Mn), By End User 2022 to 2032
TABLE 269: Singapore Market Value (US$ Mn), By Application 2017 to 2021
TABLE 270: Singapore Market Value (US$ Mn), By Application 2022 to 2032
TABLE 271: Singapore Market Value (US$ Mn), By Technology 2017 to 2021
TABLE 272: Singapore Market Value (US$ Mn), By Technology 2022 to 2032
TABLE 273: Thailand Market Value (US$ Mn), By Test Type 2017 to 2021
TABLE 274: Thailand Market Value (US$ Mn), By Test Type 2022 to 2032
TABLE 275: Thailand Market Value (US$ Mn), By End User 2017 to 2021
TABLE 276: Thailand Market Value (US$ Mn), By End User 2022 to 2032
TABLE 277: Thailand Market Value (US$ Mn), By Application 2017 to 2021
TABLE 278: Thailand Market Value (US$ Mn), By Application 2022 to 2032
TABLE 279: Thailand Market Value (US$ Mn), By Technology 2017 to 2021
TABLE 280: Thailand Market Value (US$ Mn), By Technology 2022 to 2032
TABLE 281: GCC Countries Market Value (US$ Mn), By Test Type 2017 to 2021
TABLE 282: GCC Countries Market Value (US$ Mn), By Test Type 2022 to 2032
TABLE 283: GCC Countries Market Value (US$ Mn), By End User 2017 to 2021
TABLE 284: GCC Countries Market Value (US$ Mn), By End User 2022 to 2032
TABLE 285: GCC Countries Market Value (US$ Mn), By Application 2017 to 2021
TABLE 286: GCC Countries Market Value (US$ Mn), By Application 2022 to 2032
TABLE 287: GCC Countries Market Value (US$ Mn), By Technology 2017 to 2021
TABLE 288: GCC Countries Market Value (US$ Mn), By Technology 2022 to 2032
TABLE 289: South Africa Market Value (US$ Mn), By Test Type 2017 to 2021
TABLE 290: South Africa Market Value (US$ Mn), By Test Type 2022 to 2032
TABLE 291: South Africa Market Value (US$ Mn), By End User 2017 to 2021
TABLE 292: South Africa Market Value (US$ Mn), By End User 2022 to 2032
TABLE 293: South Africa Market Value (US$ Mn), By Application 2017 to 2021
TABLE 294: South Africa Market Value (US$ Mn), By Application 2022 to 2032
TABLE 295: South Africa Market Value (US$ Mn), By Technology 2017 to 2021
TABLE 296: South Africa Market Value (US$ Mn), By Technology 2022 to 2032
TABLE 297: Nigeria Market Value (US$ Mn), By Test Type 2017 to 2021
TABLE 298: Nigeria Market Value (US$ Mn), By Test Type 2022 to 2032
TABLE 299: Nigeria Market Value (US$ Mn), By End User 2017 to 2021
TABLE 300: Nigeria Market Value (US$ Mn), By End User 2022 to 2032
TABLE 301: Nigeria Market Value (US$ Mn), By Application 2017 to 2021
TABLE 302: Nigeria Market Value (US$ Mn), By Application 2022 to 2032
TABLE 303: Nigeria Market Value (US$ Mn), By Technology 2017 to 2021
TABLE 304: Nigeria Market Value (US$ Mn), By Technology 2022 to 2032
TABLE 305: Israel Market Value (US$ Mn), By Test Type 2017 to 2021
TABLE 306: Israel Market Value (US$ Mn), By Test Type 2022 to 2032
TABLE 307: Israel Market Value (US$ Mn), By End User 2017 to 2021
TABLE 308: Israel Market Value (US$ Mn), By End User 2022 to 2032
TABLE 309: Israel Market Value (US$ Mn), By Application 2017 to 2021
TABLE 310: Israel Market Value (US$ Mn), By Application 2022 to 2032
TABLE 311: Israel Market Value (US$ Mn), By Technology 2017 to 2021
TABLE 312: Israel Market Value (US$ Mn), By Technology 2022 to 2032
List Of Figures
FIG. 01: Global Market Value (US$ Mn), 2017 to 2021
FIG. 02: Global Market Value (US$ Mn) Forecast, 2022 to 2032
FIG. 03: Global Market Value (US$ Mn) and Y-o-Y, 2017 to 2032
FIG. 04: Global Genetic Diagnosis Segment Market Value (US$ Mn) By Region, 2017 to 2021
FIG. 05: Global Genetic Diagnosis Segment Market Value (US$ Mn) By Region, 2022 to 2032
FIG. 06: Global Genetic Diagnosis Segment Y-o-Y Growth Rate, By Region, 2017 to 2032
FIG. 07: Global Genetic Screening Segment Market Value (US$ Mn) By Region, 2017 to 2021
FIG. 08: Global Genetic Screening Segment Market Value (US$ Mn) By Region, 2022 to 2032
FIG. 09: Global Genetic Screening Segment Y-o-Y Growth Rate, By Region, 2017 to 2032
FIG. 10: Global Hospitals Segment Market Value (US$ Mn) By Region, 2017 to 2021
FIG. 11: Global Hospitals Segment Market Value (US$ Mn) By Region, 2022 to 2032
FIG. 12: Global Hospitals Segment Y-o-Y Growth Rate, By Region, 2017 to 2032
FIG. 13: Global Diagnostic Labs Segment Market Value (US$ Mn) By Region, 2017 to 2021
FIG. 14: Global Diagnostic Labs Segment Market Value (US$ Mn) By Region, 2022 to 2032
FIG. 15: Global Diagnostic Labs Segment Y-o-Y Growth Rate, By Region, 2017 to 2032
FIG. 16: Global Research & Academic Institutes Segment Market Value (US$ Mn) By Region, 2017 to 2021
FIG. 17: Global Research & Academic Institutes Segment Market Value (US$ Mn) By Region, 2022 to 2032
FIG. 18: Global Research & Academic Institutes Segment Y-o-Y Growth Rate, By Region, 2017 to 2032
FIG. 19: Global Specialized Clinics Segment Market Value (US$ Mn) By Region, 2017 to 2021
FIG. 20: Global Specialized Clinics Segment Market Value (US$ Mn) By Region, 2022 to 2032
FIG. 21: Global Specialized Clinics Segment Y-o-Y Growth Rate, By Region, 2017 to 2032
FIG. 22: Global Other End Users Segment Market Value (US$ Mn) By Region, 2017 to 2021
FIG. 23: Global Other End Users Segment Market Value (US$ Mn) By Region, 2022 to 2032
FIG. 24: Global Other End Users Segment Y-o-Y Growth Rate, By Region, 2017 to 2032
FIG. 25: Global Embryo HLA Typing for Stem Cell Therapy Segment Market Value (US$ Mn) By Region, 2017 to 2021
FIG. 26: Global Embryo HLA Typing for Stem Cell Therapy Segment Market Value (US$ Mn) By Region, 2022 to 2032
FIG. 27: Global Embryo HLA Typing for Stem Cell Therapy Segment Y-o-Y Growth Rate, By Region, 2017 to 2032
FIG. 28: Global IVF Prognosis Segment Market Value (US$ Mn) By Region, 2017 to 2021
FIG. 29: Global IVF Prognosis Segment Market Value (US$ Mn) By Region, 2022 to 2032
FIG. 30: Global IVF Prognosis Segment Y-o-Y Growth Rate, By Region, 2017 to 2032
FIG. 31: Global Late-Onset Genetic Disorders Segment Market Value (US$ Mn) By Region, 2017 to 2021
FIG. 32: Global Late-Onset Genetic Disorders Segment Market Value (US$ Mn) By Region, 2022 to 2032
FIG. 33: Global Late-Onset Genetic Disorders Segment Y-o-Y Growth Rate, By Region, 2017 to 2032
FIG. 34: Global Inherited Genetic Disease Segment Market Value (US$ Mn) By Region, 2017 to 2021
FIG. 35: Global Inherited Genetic Disease Segment Market Value (US$ Mn) By Region, 2022 to 2032
FIG. 36: Global Inherited Genetic Disease Segment Y-o-Y Growth Rate, By Region, 2017 to 2032
FIG. 37: Global Other Applications Segment Market Value (US$ Mn) By Region, 2017 to 2021
FIG. 38: Global Other Applications Segment Market Value (US$ Mn) By Region, 2022 to 2032
FIG. 39: Global Other Applications Segment Y-o-Y Growth Rate, By Region, 2017 to 2032
FIG. 40: Global NGS Segment Market Value (US$ Mn) By Region, 2017 to 2021
FIG. 41: Global NGS Segment Market Value (US$ Mn) By Region, 2022 to 2032
FIG. 42: Global NGS Segment Y-o-Y Growth Rate, By Region, 2017 to 2032
FIG. 43: Global PCR Segment Market Value (US$ Mn) By Region, 2017 to 2021
FIG. 44: Global PCR Segment Market Value (US$ Mn) By Region, 2022 to 2032
FIG. 45: Global PCR Segment Y-o-Y Growth Rate, By Region, 2017 to 2032
FIG. 46: Global FISH Segment Market Value (US$ Mn) By Region, 2017 to 2021
FIG. 47: Global FISH Segment Market Value (US$ Mn) By Region, 2022 to 2032
FIG. 48: Global FISH Segment Y-o-Y Growth Rate, By Region, 2017 to 2032
FIG. 49: Global CGH Segment Market Value (US$ Mn) By Region, 2017 to 2021
FIG. 50: Global CGH Segment Market Value (US$ Mn) By Region, 2022 to 2032
FIG. 51: Global CGH Segment Y-o-Y Growth Rate, By Region, 2017 to 2032
FIG. 52: Global SNP Segment Market Value (US$ Mn) By Region, 2017 to 2021
FIG. 53: Global SNP Segment Market Value (US$ Mn) By Region, 2022 to 2032
FIG. 54: Global SNP Segment Y-o-Y Growth Rate, By Region, 2017 to 2032
FIG. 55: North America Market Value (US$ Mn), By Test Type 2017 to 2021
FIG. 56: North America Market Value (US$ Mn), By Test Type 2022 to 2032
FIG. 57: North America Market Value (US$ Mn), By End User 2017 to 2021
FIG. 58: North America Market Value (US$ Mn), By End User 2022 to 2032
FIG. 59: North America Market Value (US$ Mn), By Application 2017 to 2021
FIG. 60: North America Market Value (US$ Mn), By Application 2022 to 2032
FIG. 61: North America Market Value (US$ Mn), By Technology 2017 to 2021
FIG. 62: North America Market Value (US$ Mn), By Technology 2022 to 2032
FIG. 63: Latin America Market Value (US$ Mn), By Test Type 2017 to 2021
FIG. 64: Latin America Market Value (US$ Mn), By Test Type 2022 to 2032
FIG. 65: Latin America Market Value (US$ Mn), By End User 2017 to 2021
FIG. 66: Latin America Market Value (US$ Mn), By End User 2022 to 2032
FIG. 67: Latin America Market Value (US$ Mn), By Application 2017 to 2021
FIG. 68: Latin America Market Value (US$ Mn), By Application 2022 to 2032
FIG. 69: Latin America Market Value (US$ Mn), By Technology 2017 to 2021
FIG. 70: Latin America Market Value (US$ Mn), By Technology 2022 to 2032
FIG. 71: Europe Market Value (US$ Mn), By Test Type 2017 to 2021
FIG. 72: Europe Market Value (US$ Mn), By Test Type 2022 to 2032
FIG. 73: Europe Market Value (US$ Mn), By End User 2017 to 2021
FIG. 74: Europe Market Value (US$ Mn), By End User 2022 to 2032
FIG. 75: Europe Market Value (US$ Mn), By Application 2017 to 2021
FIG. 76: Europe Market Value (US$ Mn), By Application 2022 to 2032
FIG. 77: Europe Market Value (US$ Mn), By Technology 2017 to 2021
FIG. 78: Europe Market Value (US$ Mn), By Technology 2022 to 2032
FIG. 79: Japan Market Value (US$ Mn), By Test Type 2017 to 2021
FIG. 80: Japan Market Value (US$ Mn), By Test Type 2022 to 2032
FIG. 81: Japan Market Value (US$ Mn), By End User 2017 to 2021
FIG. 82: Japan Market Value (US$ Mn), By End User 2022 to 2032
FIG. 83: Japan Market Value (US$ Mn), By Application 2017 to 2021
FIG. 84: Japan Market Value (US$ Mn), By Application 2022 to 2032
FIG. 85: Japan Market Value (US$ Mn), By Technology 2017 to 2021
FIG. 86: Japan Market Value (US$ Mn), By Technology 2022 to 2032
FIG. 87: APEJ Market Value (US$ Mn), By Test Type 2017 to 2021
FIG. 88: APEJ Market Value (US$ Mn), By Test Type 2022 to 2032
FIG. 89: APEJ Market Value (US$ Mn), By End User 2017 to 2021
FIG. 90: APEJ Market Value (US$ Mn), By End User 2022 to 2032
FIG. 91: APEJ Market Value (US$ Mn), By Application 2017 to 2021
FIG. 92: APEJ Market Value (US$ Mn), By Application 2022 to 2032
FIG. 93: APEJ Market Value (US$ Mn), By Technology 2017 to 2021
FIG. 94: APEJ Market Value (US$ Mn), By Technology 2022 to 2032
FIG. 95: MEA Market Value (US$ Mn), By Test Type 2017 to 2021
FIG. 96: MEA Market Value (US$ Mn), By Test Type 2022 to 2032
FIG. 97: MEA Market Value (US$ Mn), By End User 2017 to 2021
FIG. 98: MEA Market Value (US$ Mn), By End User 2022 to 2032
FIG. 99: MEA Market Value (US$ Mn), By Application 2017 to 2021
FIG. 100: MEA Market Value (US$ Mn), By Application 2022 to 2032
FIG. 101: MEA Market Value (US$ Mn), By Technology 2017 to 2021
FIG. 102: MEA Market Value (US$ Mn), By Technology 2022 to 2032
- FAQs -
Which segment is likely to be the most prominent area for preimplantation genetic testing?
By Application type, Testing for embryo HLA typing for stem cell therapy is likely to generate incremental opportunity exceeding US$ 70 Mn by 2032.
At what value will the Preimplantation Genetic Testing market close in 2022?
As of 2022, Fact.MR expects the Preimplantation Genetic Testing industry to be valued at US$ 653.52 Million.
At what percentage will the industry expand during the 2022 to 2032 period of assessment?
From 2022 to 2032, the Preimplantation Genetic Testing industry is poised to flourish at a 9% CAGR.
What is the expected closing market value for Preimplantation Genetic Testing in 2032?
By 2032, the Preimplantation Genetic Testing landscape is slated to reach a valuation of US$ 1420 Million.
From 2017 to 2021, what was the documented growth rate for the Preimplantation Genetic Testing market?
According to Fact.MR, a CAGR of 8% was recorded for the Preimplantation Genetic Testing market from 2017 to 2021.
How will the Asia Pacific market for Preimplantation Genetic Testing flourish until 2032?
As per Fact.MR’s projections, the market for Preimplantation Genetic Testing in Europe will likely expand at a 60% CAGR.
What was the market worth for Preimplantation Genetic Testing in 2021?
As of 2021, the Preimplantation Genetic Testing market was valued at US$ 599.53 Million.
Related Reports
Preimplantation Genetic Testing Market